Literature DB >> 29510142

The P1 visual-evoked potential, red light, and transdiagnostic psychiatric symptoms.

Jeffrey S Bedwell1, Christopher C Spencer2, Chi C Chan2, Pamela D Butler3, Pejman Sehatpour4, Joseph Schmidt2.   

Abstract

A reduced P1 visual-evoked potential amplitude has been reported across several psychiatric disorders, including schizophrenia-spectrum, bipolar, and depressive disorders. In addition, a difference in P1 amplitude change to a red background compared to its opponent color, green, has been found in schizophrenia-spectrum samples. The current study examined whether specific psychiatric symptoms that related to these P1 abnormalities in earlier studies would be replicated when using a broad transdiagnostic sample. The final sample consisted of 135 participants: 26 with bipolar disorders, 25 with schizophrenia-spectrum disorders, 19 with unipolar depression, 62 with no current psychiatric disorder, and 3 with disorders in other categories. Low (8%) and high (64%) contrast check arrays were presented on gray, green, and red background conditions during electroencephalogram, while an eye tracker monitored visual fixation on the stimuli. Linear regressions across the entire sample (N = 135) found that greater severity of both clinician-rated and self-reported delusions/magical thinking correlated with a reduced P1 amplitude on the low contrast gray (neutral) background condition. In addition, across the entire sample, higher self-reported constricted affect was associated with a larger decrease in P1 amplitude (averaged across contrast conditions) to the red, compared to green, background. All relationships remained statistically significant after covarying for diagnostic class, suggesting that they are relatively transdiagnostic in nature. These findings indicate that early visual processing abnormalities may be more directly related to specific transdiagnostic symptoms such as delusions and constricted affect rather than specific psychiatric diagnoses or broad symptom factor scales.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Bipolar; Depression; EEG; Event-related potentials; Schizophrenia; Visual-evoked potentials

Mesh:

Year:  2018        PMID: 29510142      PMCID: PMC5882500          DOI: 10.1016/j.brainres.2018.03.002

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  44 in total

1.  Toward a more psychometrically sound brief measure of schizotypal traits: introducing the SPQ-Brief Revised.

Authors:  Alex S Cohen; Russell A Matthews; Gina M Najolia; Laura A Brown
Journal:  J Pers Disord       Date:  2010-08

2.  From perception to functional outcome in schizophrenia: modeling the role of ability and motivation.

Authors:  Michael F Green; Gerhard Hellemann; William P Horan; Junghee Lee; Jonathan K Wynn
Journal:  Arch Gen Psychiatry       Date:  2012-12

3.  Differential relationships of mismatch negativity and visual p1 deficits to premorbid characteristics and functional outcome in schizophrenia.

Authors:  Tamara Friedman; Pejman Sehatpour; Elisa Dias; Megan Perrin; Daniel C Javitt
Journal:  Biol Psychiatry       Date:  2011-12-21       Impact factor: 13.382

4.  Subcortical visual dysfunction in schizophrenia drives secondary cortical impairments.

Authors:  Pamela D Butler; Antigona Martinez; John J Foxe; Dongsoo Kim; Vance Zemon; Gail Silipo; Jeannette Mahoney; Marina Shpaner; Maria Jalbrzikowski; Daniel C Javitt
Journal:  Brain       Date:  2006-09-19       Impact factor: 13.501

5.  The beneficial influence of inattention on visual interference in schizophrenia.

Authors:  Mathieu B Brodeur; Michael Kiang; Bruce K Christensen
Journal:  Neuropsychology       Date:  2016-03-10       Impact factor: 3.295

6.  Visual sensory processing deficits in patients with bipolar disorder revealed through high-density electrical mapping.

Authors:  Sherlyn Yeap; Simon P Kelly; Richard B Reilly; Jogin H Thakore; John J Foxe
Journal:  J Psychiatry Neurosci       Date:  2009-11       Impact factor: 6.186

7.  Changes in the visual-evoked P1 potential as a function of schizotypy and background color in healthy young adults.

Authors:  Jeffrey S Bedwell; Chi C Chan; Benjamin J Trachik; Yuri Rassovsky
Journal:  J Psychiatr Res       Date:  2013-01-29       Impact factor: 4.791

8.  Heterogeneity of information-processing alterations according to dimensions of depression: an event-related potentials study.

Authors:  A Pierson; R Ragot; J Van Hooff; A Partiot; B Renault; R Jouvent
Journal:  Biol Psychiatry       Date:  1996-07-15       Impact factor: 13.382

9.  Visual perception and its impairment in schizophrenia.

Authors:  Pamela D Butler; Steven M Silverstein; Steven C Dakin
Journal:  Biol Psychiatry       Date:  2008-07-01       Impact factor: 13.382

Review 10.  High-frequency neural oscillations and visual processing deficits in schizophrenia.

Authors:  Heng-Ru May Tan; Luiz Lana; Peter J Uhlhaas
Journal:  Front Psychol       Date:  2013-10-09
View more
  4 in total

1.  Childhood Cat Bites Relate to Increased Adulthood Severity of Schizotypy, Psychotic-Like Experiences, and Social Anhedonia in a Transdiagnostic Psychiatric Sample.

Authors:  Jeffrey S Bedwell; Christopher C Spencer; Amber L Southwell
Journal:  Psychopathology       Date:  2020-03-27       Impact factor: 1.944

2.  Event-related potentials to rare visual targets and negative symptom severity in a transdiagnostic psychiatric sample.

Authors:  Giulia C Salgari; Geoffrey F Potts; Joseph Schmidt; Chi C Chan; Christopher C Spencer; Jeffrey S Bedwell
Journal:  Clin Neurophysiol       Date:  2021-04-09       Impact factor: 4.861

3.  Resting state functional connectivity predictors of treatment response to electroconvulsive therapy in depression.

Authors:  M Moreno-Ortega; J Prudic; S Rowny; G H Patel; A Kangarlu; S Lee; J Grinband; T Palomo; T Perera; M F Glasser; D C Javitt
Journal:  Sci Rep       Date:  2019-03-25       Impact factor: 4.379

Review 4.  Visual system assessment for predicting a transition to psychosis.

Authors:  Alexander Diamond; Steven M Silverstein; Brian P Keane
Journal:  Transl Psychiatry       Date:  2022-08-29       Impact factor: 7.989

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.